Skip to main content

Advertisement

SpringerLink
Log in

Bladder pain syndrome/interstitial cystitis: a sense of urgency

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

A classic triad of symptoms (bladder pain, urinary frequency, and urgency) has served to define bladder pain syndrome/painful bladder syndrome/interstitial cystitis (BPS/PBS/IC) syndrome. BPS/PBS/IC is a distinct condition and it is likely that the urgency experienced by these patients differs from that experienced by those with overactive bladder syndrome. It is unclear how best to define urgency in the BPS/PBS/IC setting. Differences in the other primary symptoms associated with these conditions probably influence how urgency is perceived. Advances in research into the pathophysiology of urgency and underlying disease processes will help to optimize both the diagnosis and treatment of BPS/PBS/IC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ware J (1955) The analects of Confucius. Mentor Religious Classic, New American Library, New York

    Google Scholar 

  2. Abrams PH, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn 21:167–178

    Article  PubMed  Google Scholar 

  3. Hanno PM (2008) Re-imagining interstitial cystitis. Urol Clin North Am 35:91–99

    Article  PubMed  Google Scholar 

  4. Digesu G, Khullar V, Panayi D et al (2008) Should we explain lower urinary tract symptoms to patients? Neurourol Urodyn 27:368–371

    Article  PubMed  Google Scholar 

  5. Merskey H, Bogduk N (1994) Classification of chronic pain, 2nd edn. IASP Press, Seattle

    Google Scholar 

  6. Homma Y (2008) Lower urinary tract symptomatology: its definition and confusion. Int J Urol 15:35–43

    PubMed  Google Scholar 

  7. Bourque JP (1951) Surgical management of the painful bladder. J Urol 65:25–34

    CAS  PubMed  Google Scholar 

  8. Warren JW, Meyer WA, Greenberg P et al (2006) Using the International Continence Society’s definition of painful bladder syndrome. Urology 67:1138–1142

    Article  PubMed  Google Scholar 

  9. Abrams P, Hanno P, Wein A (2005) Overactive bladder and painful bladder syndrome: there need not be confusion. Neurourol Urodyn 24:149–150

    Article  PubMed  Google Scholar 

  10. Simon LJ, Landis JR, Tomaszewski JE (1997) The interstitial cystitis database (ICDB) study. In: Sant GR et al (eds) Interstitial cystitis. Lippincott, Philadelphia, pp 17–24

    Google Scholar 

  11. O’Leary MP, Sant GR, Fowler FJ Jr et al (1997) The interstitial cystitis symptom index and problem index. Urology 49(5A Suppl):58–63

    Article  PubMed  Google Scholar 

  12. Held PJ, Hanno PM, Wein AJ (1990) Epidemiology of interstitial cystitis. In: Hanno PM, Staskin DR, Krane RJ, Wein AJ (eds) Interstitial cystitis. Springer, London, pp 29–48

    Google Scholar 

  13. Warren JW, Diggs C, Brown V et al (2006) Dysuria at onset of interstitial cystitis/painful bladder syndrome in women. Urology 68:477–481

    Article  PubMed  Google Scholar 

  14. Diggs C, Meyer WA, Langenberg P et al (2007) Assessing urgency in interstitial cystitis/painful bladder syndrome. Urology 69:210–214

    Article  PubMed  Google Scholar 

  15. Greenberg P, Brown J, Yates T et al (2008) Voiding urges perceived by patients with interstitial cystitis/painful bladder syndrome. Neurourol Urodyn 27:287–290

    Article  PubMed  Google Scholar 

  16. Van De Merwe J, Nordling J, Bouchelouche K et al (2008) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53:60–67

    Article  PubMed  Google Scholar 

  17. Yamaguchi O, Honda K, Nomiya M et al (2007) Defining overactive bladder as hypersensitivity. Neurourol Urodyn 26:904–907

    Article  PubMed  Google Scholar 

  18. Yoshimura N (2007) Lower urinary tract symptoms (LUTS) and bladder afferent activity. Neurourol Urodyn 26:908–913

    Article  CAS  PubMed  Google Scholar 

  19. Haylen BT, Chetty N, Logan V et al (2007) Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity? Int Urogynecol 18:123–128

    Article  Google Scholar 

  20. Hanno P, Baranowski A, Fall M (2005) Painful bladder syndrome (including interstitial cystitis). In: Abrams PH, Wein AJ, Cardozo L et al (eds) Incontinence, 3rd edn. Health Publications Limited, Paris, pp 1456–1520

    Google Scholar 

  21. Stewart W, Van Rooyen J, Cundiff G et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–336

    CAS  PubMed  Google Scholar 

  22. Payne CK, Joyce GF, Wise M et al (2007) Interstitial cystitis and painful bladder syndrome. J Urol 177:2042–2049

    Article  PubMed  Google Scholar 

  23. Clemens JQ, Meenan RT, O’Keeffe Rosetti MC et al (2005) Prevalence of interstitial cystitis symptoms in a managed care population. J Urol 174:576–580

    Article  PubMed  Google Scholar 

  24. Bade JJ, Hollants F, Gerkens F et al (2000) The efficacy of intravesical oxybutynin and pentosanpolysulfate in the treatment of interstitial cystitis: a prospective, double-blind trial. J Urol 163S:60

    Google Scholar 

  25. MacDiarmid SA, Sand PK (2007) Diagnosis of interstitial cystitis/painful bladder syndrome in patients with overactive bladder symptoms. Rev Urol 9:9–16

    PubMed  Google Scholar 

Download references

Acknowledgments

During the last year PH has worked with Watson. CRC has received funding from Astellas, Pfizer, Novartis, Allergan and Recordat. During the last year LC has worked with the following companies as a lecturer, advisor or researcher; Astellas, Pfizer, Allergan, Bioxell, Rottapharm, Schering Plough.

Conflict of interest statement

None.

Author information

Authors and Affiliations

  1. Hospital of the University of Pennsylvania, University of Pennsylvania, 9 Penn Tower, 3400 Spruce Street, Philadelphia, PA, 19104, USA

    Philip M. Hanno

  2. Royal Hallamshire Hospital, Sheffield, UK

    Chris R. Chapple

  3. King’s College Hospital, London, UK

    Linda D. Cardozo

Authors
  1. Philip M. Hanno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chris R. Chapple
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Linda D. Cardozo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philip M. Hanno.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hanno, P.M., Chapple, C.R. & Cardozo, L.D. Bladder pain syndrome/interstitial cystitis: a sense of urgency. World J Urol 27, 717–721 (2009). https://doi.org/10.1007/s00345-009-0439-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-009-0439-4

Keywords

Search

Navigation